MeSH term
Frequency | Condition_Probility | Humans | 55 | 0.0 |
Chromosome Mapping | 8 | 0.0 |
Chromosomes, Human, Pair 11/*genetics | 5 | 2.0 |
Chromosomes, Human, Pair 21/*genetics | 2 | 2.0 |
Genes, Tumor Suppressor | 2 | 0.0 |
Polymerase Chain Reaction | 11 | 0.0 |
Research Support, Non-U.S. Gov't | 46 | 0.0 |
Sequence Analysis, DNA | 6 | 0.0 |
Adolescent | 15 | 0.0 |
Adult | 17 | 0.0 |
Child | 14 | 0.0 |
Child, Preschool | 9 | 0.0 |
Comparative Study | 9 | 0.0 |
Female | 19 | 0.0 |
Follow-Up Studies | 2 | 0.0 |
Male | 18 | 0.0 |
Potassium Channels/genetics | 2 | 4.0 |
*Potassium Channels, Voltage-Gated | 2 | 0.0 |
Prognosis | 6 | 0.0 |
*Proto-Oncogene Proteins | 14 | 0.0 |
RNA-Binding Protein EWS | 6 | 21.0 |
Trans-Activators/genetics | 8 | 3.0 |
Translocation, Genetic | 3 | 0.0 |
3T3 Cells | 7 | 0.0 |
Amino Acid Sequence | 10 | 0.0 |
Animals | 20 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Mice | 15 | 0.0 |
Molecular Sequence Data | 19 | 0.0 |
Oncogene Proteins, Fusion/genetics/*physiology | 3 | 16.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 21 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Trans-Activation (Genetics)/physiology | 2 | 2.0 |
Transcription Factors/genetics/*physiology | 3 | 1.0 |
Binding Sites | 4 | 0.0 |
DNA-Binding Proteins/*genetics | 10 | 0.0 |
Exons | 5 | 0.0 |
Transcription Factors/*genetics | 7 | 0.0 |
*Translocation, Genetic | 8 | 0.0 |
RNA, Neoplasm/analysis | 3 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction | 8 | 0.0 |
Tumor Markers, Biological/analysis | 2 | 0.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
*Repressor Proteins | 4 | 0.0 |
Phenotype | 5 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Trans-Activators/*genetics | 5 | 1.0 |
*Transcription Factors | 3 | 0.0 |
Antineoplastic Agents/therapeutic use | 2 | 0.0 |
*Gene Deletion | 3 | 0.0 |
Treatment Outcome | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Prospective Studies | 2 | 0.0 |
Base Sequence | 15 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Cell Line | 3 | 0.0 |
Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Gene Rearrangement | 4 | 0.0 |
Hela Cells | 4 | 0.0 |
Sarcoma, Ewing's/*genetics/metabolism | 2 | 50.0 |
Transcription Factors/*genetics/metabolism | 2 | 0.0 |
Tumor Cells, Cultured | 10 | 0.0 |
DNA Primers | 4 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 2 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Syndrome | 2 | 0.0 |
Thrombocytopenia/blood/*genetics | 2 | 33.0 |
Trans-Activators/*genetics/metabolism | 2 | 1.0 |
Transfection | 8 | 0.0 |
Cell Differentiation | 2 | 0.0 |
DNA-Binding Proteins/genetics | 5 | 0.0 |
*Proto-Oncogenes | 2 | 0.0 |
Aged | 4 | 0.0 |
*DNA-Binding Proteins | 3 | 0.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Middle Aged | 4 | 0.0 |
*Trans-Activators | 3 | 0.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
Evolution, Molecular | 2 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
Infant, Newborn | 2 | 0.0 |
Trans-Activation (Genetics) | 3 | 0.0 |
Chromosomes, Human, Pair 11 | 3 | 0.0 |
Karyotyping | 2 | 0.0 |
Oncogene Proteins, Fusion/*genetics | 4 | 2.0 |
Sarcoma, Ewing's/*genetics | 12 | 26.0 |
*Gene Expression Regulation, Neoplastic | 4 | 0.0 |
Leukemia/*genetics | 2 | 1.0 |
*Transcription, Genetic | 4 | 0.0 |
Bone Neoplasms/*genetics | 2 | 4.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Sequence Deletion | 3 | 0.0 |
Chimeric Proteins/*genetics | 3 | 16.0 |
Blotting, Southern | 4 | 0.0 |
*Chromosome Aberrations | 3 | 0.0 |
Genes, myc | 2 | 0.0 |
Proto-Oncogene Proteins/genetics | 3 | 0.0 |
Transcription Factors/genetics | 4 | 0.0 |
Transcription, Genetic | 7 | 0.0 |
Chromosomes, Human, Pair 22/*genetics | 2 | 2.0 |
DNA, Neoplasm/analysis | 2 | 0.0 |
Oncogene Proteins, Fusion/genetics | 2 | 2.0 |
Translocation, Genetic/*genetics | 2 | 0.0 |
Transcription Factors/*physiology | 2 | 0.0 |
DNA Primers/chemistry | 2 | 0.0 |
Cloning, Molecular | 7 | 0.0 |
Gene Expression | 2 | 0.0 |
Gene Fusion | 3 | 3.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Oncogene Proteins, Fusion/genetics/*metabolism | 2 | 5.0 |
Transcription Factors/genetics/*metabolism | 3 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Mutation | 4 | 0.0 |
Infant | 3 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 2 | 0.0 |
Heterogeneous-Nuclear Ribonucleoproteins | 5 | 4.0 |
In Situ Hybridization, Fluorescence | 6 | 0.0 |
RNA-Binding Proteins/*genetics | 3 | 2.0 |
RNA-Directed DNA Polymerase | 2 | 1.0 |
Ribonucleoproteins/*genetics | 3 | 6.0 |
Up-Regulation | 2 | 0.0 |
Nuclear Proteins/*genetics | 2 | 0.0 |
Chromosomes, Artificial, Yeast | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
*Chromosomes, Human, Pair 11 | 2 | 0.0 |
Friend murine leukemia virus/*genetics | 2 | 66.0 |
*Virus Integration | 2 | 2.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Sarcoma, Ewing's/genetics/*metabolism | 2 | 66.0 |
